NanoEcho
0,15
SEK
-5,06 %
NANECH
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Vær den første som følger denne virksomhed
-5,06%
+16,46%
-55,82%
-
-
-
-
-
-16,62%
NanoEcho is active in healthcare, with a main focus in rectal cancer diagnostics. The company is active in the clinical stage, where a new diagnostic method is being developed to determine whether early rectal cancer has spread to nearby lymph nodes. The method aims to provide a correct diagnosis and individualized treatment. NanoEcho was founded in 2013 and has its headquarters in Lund.
Læs mereMarkedsværdi
26,07 mio. SEK
Aktieomsætning
42,18 t SEK
Omsætning
-
EBIT %
-
P/E
-
Udbytteafkast, %
-
Finanskalender
13.2
2025
Årsrapport '24
30.4
2025
Delårsrapport Q1'25
21.8
2025
Delårsrapport Q2'25